共 304 条
[31]
Burton DR(1997)Protectionagainst HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site Nat Med 3 1389-1393
[32]
Pyati J(1999)Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1 J Virol 73 4009-4018
[33]
Koduri R(1998)Protection of macaques against pathogenic SHIV-89.6PD by passive transfer of neutralizing antibodies AIDS Res Hum Retroviruses 14 1035-1043
[34]
Burton DR(1999)Neutralizing antibodies administered before, but not after, virulent SHIV prevent infection in macaques Nat Med 5 189-193
[35]
Barbas CF(1999)Requirement for multiple lymphocyte subsets in protection against retroviral infection by a live-attenuated vaccine Immunity 10 1-20
[36]
Persson MAA(1998)Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo J Virol 72 10,270-10,274
[37]
Koenig S(1997)Antibody neutralization-resistant primary isolates of human immunodeficiency virus type-1 J Virol 71 6869-6874
[38]
Chanock RM(1992)Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1 b12 Proc Natl Acad Sci USA 89 10,164-10,168
[39]
Lerner RA(1994)Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity Proc Natl Acad Sci USA 91 1386-1390
[40]
Ditzel HJ(1999)Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice J Virol 65 18-56